Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab

Related articles

08 Jun 2020 : Laboratory Research

Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis

Qiaohong Bai, Li Li, [...] Futao Chen, Jiang Zhu, Lifeng Cao, Yang Yang, Fukuan Zhong - Show fewer authors

DOI: 10.12659/MSM.921200

19 Apr 2020 : Clinical Research

Influence of Hypertension on the Survival of Non-Small Cell Lung Cancer Patients with Type 2 Diabetes Mellitus

Xianghua Zeng, Dong Zeng, [...] Jianan Cheng, Cheng Xu, Chengdu Sun, Haixia Long, Bo Zhu - Show fewer authors

DOI: 10.12659/MSM.921676

18 Feb 2020 : Clinical Research

Altered Dynamic Neural Activity in the Default Mode Network in Lung Cancer Patients After Chemotherapy

Jia You, Lanyue Hu, [...] Yujie Zhang, Feifei Chen, Xindao Yin, Mingxu Jin, Yu-Chen Chen - Show fewer authors

DOI: 10.12659/MSM.921700

13 Jul 2020 : Database Analysis

Prediction of Specific Subtypes and Common Markers of Non-Small Cell Lung Cancer Based on Competing Endogenous RNA Network

Yao Liu, Hao Wang, [...] Wenhan Yang, Youhui Qian - Show fewer authors

DOI: 10.12659/MSM.922280

01 Jun 2020 : Database Analysis

A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Zhulin Wu, Chensheng Ouyang, [...] Lisheng Peng - Show fewer authors

DOI: 10.12659/MSM.923231

09 May 2020 : Clinical Research

CircPSMC3 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Cells via miR-182-5p/NME2 Axis

Tao Xu, Yejun Yu, [...] Shengcong Guo, Lixiang He, Zejun Mao - Show fewer authors

DOI: 10.12659/MSM.924134

24 Sep 2019 : Case report

Calcineurin Inhibitors and Neutropenia: Is Cyclosporine Superior to Tacrolimus?

Tanu Duggal, Meghan Dempster, [...] Rohini Prashar - Show fewer authors

DOI: 10.12659/AJCR.917282

25 Jul 2017 : Original article

Acute Cellular Rejection in ABO-Incompatible Renal Transplant Recipients Receiving Rituximab Is Associated with Delayed-Onset Neutropenia

Junji Uchida, Tomoaki Iwai, [...] Shunji Nishide, Kazuya Kabei, Nobuyuki Kuwabara, Takeshi Yamasaki, Toshihide Naganuma, Norihiko Kumada, Yoshiaki Takemoto, Tatsuya Nakatani - Show fewer authors

DOI: 10.12659/AOT.902236

09 Apr 2015 : Case report

Rituximab-Related Late-Onset Neutropenia in Patients with Rheumatic Diseases: Successful Re-Challenge of the Treatment

Tatiana Reitblat, Alexander Wechsler, [...] Olga Reitblat - Show fewer authors

DOI: 10.12659/AJCR.892541

05 Oct 2014 : Original article

Independent Factors for Prediction of Poor Outcomes in Patients with Febrile Neutropenia

Müge Günalp, Merve Koyunoğlu, [...] Serdar Gürler, Ayça Koca, İlker Yeşilkaya, Emre Öner, Meltem Akkaş, Nalan Metin Aksu, Arda Demirkan, Onur Polat, Atilla Halil Elhan - Show fewer authors

DOI: 10.12659/MSM.892269

26 Oct 2011

Rituximab associated neutropenia: Description of three cases and an insight into the underlying pathogenesis

Alina Weissmann-Brenner, Baruch Brenner, [...] Inessa Belyaeva, Meir Lahav, Esther Rabizadeh - Show fewer authors

DOI: 10.12659/MSM.882034

01 Feb 2004

G-CSF in solid tumor chemotherapy: a tailored regimen reduces febrile neutropenia, treatment delays and direct costs

Nicolas Tsavaris, Christos Kosmas, [...] Panagiotis Gouveris, Maria Vadiak, Antonis Dimitrakopoulos, Dimitra Karadima, Efterpi Pagouni, George Panagiotakopoulos, Evanthia Tzima, Sevasti Ispoglou, Dimitris Sakelariou, Christos Koufos - Show fewer authors

01 Nov 2004

Ceftriaxone monotherapy for the treatment of febrile neutropenia in patients with solid tumors: a prospective study of 100 episodes

Emmanuel Chamorey, Nicolas Magne, [...] Cyril Foa, Josiane Otto, Remy Largillier, Michele Viot, Isabelle Benard-Thiery, Antoine Thyss - Show fewer authors